Blueprint Medicines
BPMC
#2524
Rank
A$8.71 B
Marketcap
$137.51
Share price
0.81%
Change (1 day)
74.54%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$13.81

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$13.78. In 2022 the company made an earnings per share (EPS) of -$14.02 an increase over its 2021 EPS that were of -$16.47.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$13.81-1.5%
2022-$14.02-14.85%
2021-$16.47-297.13%
2020$8.35-176.3%
2019-$10.9535.19%
2018-$8.1038.82%
2017-$5.8347.35%
2016-$3.969.25%
2015-$3.62-31.35%
2014-$5.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.10-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.40-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.90-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA